MCAZ clarifies Nifedipine recall applies only to specific batches

The Medicines Control Authority of Zimbabwe (MCAZ) clarified that its recent recall of Nifedipine only applies to specific Nifelat 10mg batches, not all versions of the blood pressure medicine. The clarification followed public confusion after the initial recall announcement, and MCAZ is the drug regulatory authority, and the initial recall announcement caused confusion among patients. The recall was due to quality concerns identified during routine testing. MCAZ urged patients to consult healthcare providers if they have the affected batches. The recall affected only specific batches. Patients were advised to check their medication and consult a healthcare provider if concerned, and the recall is a normal routine standard regulatory action.